| Literature DB >> 28484430 |
Nadja A Henke1, Sabine A E Heider1, Silvin Hannibal1, Volker F Wendisch1, Petra Peters-Wendisch1.
Abstract
Corynebacterium glutamicum is a natural producer of the C50 carotenoid decaprenoxanthin. The crtEcg0722crtBIYEb operon comprises most of its genes for terpenoid biosynthesis. The MarR-type regulator encoded upstream and in divergent orientation of the carotenoid biosynthesis operon has not yet been characterized. This regulator, named CrtR in this study, is encoded in many actinobacterial genomes co-occurring with terpenoid biosynthesis genes. CrtR was shown to repress the crt operon of C. glutamicum since DNA microarray experiments revealed that transcript levels of crt operon genes were increased 10 to 70-fold in its absence. Transcriptional fusions of a promoter-less gfp gene with the crt operon and crtR promoters confirmed that CrtR represses its own gene and the crt operon. Gel mobility shift assays with purified His-tagged CrtR showed that CrtR binds to a region overlapping with the -10 and -35 promoter sequences of the crt operon. Isoprenoid pyrophosphates interfered with binding of CrtR to its target DNA, a so far unknown mechanism for regulation of carotenogenesis. The molecular details of protein-ligand interactions remain to be studied. Decaprenoxanthin synthesis by C. glutamicum wild type was enhanced 10 to 30-fold upon deletion of crtR and was decreased 5 to 6-fold as result of crtR overexpression. Moreover, deletion of crtR was shown as metabolic engineering strategy to improve production of native and non-native carotenoids including lycopene, β-carotene, C.p. 450 and sarcinaxanthin.Entities:
Keywords: CrtR; MarR-type regulators; actinobacteria; isoprenoid pyrophosphates as inducers; regulation of carotenogenesis; terpenoid biosynthesis
Year: 2017 PMID: 28484430 PMCID: PMC5401885 DOI: 10.3389/fmicb.2017.00633
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains, plasmids and oligonucleotides used in this study.
| DH5α | F− | Hanahan, |
| BL21 (DE3) | F− | Novagen |
| WT | ATCC 13032 | Abe et al., |
| WTΔ | cg0725 ( | this work |
| MB001 | ATCC 13032 with in-frame deletion of prophages cgp1 (cg1507-cg1524), cgp2 (cg1746-cg1752), and cgp3 (cg1890-cg2071) | Baumgart et al., |
| MB001Δ | cg0725 ( | this work |
| LYC5 | Henke et al., | |
| LYC5Δ | cg0725 ( | this work |
| BETA3 | LYC5 derivative with | Henke et al., |
| BETA3 Δ | cg0725 ( | this work |
| pK19 | KmR; | Schäfer et al., |
| pK19 | pK19 | Henke et al., |
| pVWEx1 | KmR; | Peters-Wendisch et al., |
| pVWEx1- | pVWEx1 derivative for IPTG-inducible expression of cg0725 from | this work |
| pEKEx3 | SpecR; | Stansen et al., |
| pEKEx3- | pEKEx3 derivative for IPTG-inducible expression of | Heider et al., |
| pEKEx3- | pEKEx3 derivative for IPTG-inducible expression of | Heider et al., |
| pEPR1 | KanR; vector for transcriptional fusion analysis with the promoter-less | Knoppova et al., |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pEPR1-P | pEPR1 derivate with 5′UTR region of | this work |
| pET16b | Amp | Novagen |
| pET16b- | pET16b derivative for the purification of His-tagged CrtR of | this work |
| AAAA | ||
| AAAA | ||
| SFT3 | ATTCAGCATAGTAATCACCT | |
| SFT4 | CATAAAAATAATGTGCCTAC | |
| SFT8 | TCGAGTATCACACGGCCA | |
| SFT10 | AACTCATGGGATACTATAAATTTC | |
| SFT12 | AAAAATATTAACTCATGGGATACT | |
| SFT23 | AAAAATATTAACTCATGGGATACTAT | |
| SFT25 | AAAAATA | |
| SFT26 | AAAAATA | |
| SFT27 | CACCAATACTACGTTCCACAT | |
| SFT28 | GCCTACAAGAAATTTATAGTAT | |
| SFT29 | CCCATGAGTTAATATTTTTAAAAAT | |
| SFT30 | AAAAATAAACTTTATCTGACTTTGT | |
| cg2228_fw | CTCAGGCATGATGATGTCAGGC | |
| cg2228_rv | GTTCGCTACGTCCGAGTGATCACC | |
| GCGCGAAGATTTGATGGG | ||
| ACTTGTCACCACAGCACTAC | ||
| P | ||
| P | ||
| P | ||
| P | ||
| SDM-fw-nat | TAGTATCCCATGAGTTAATATTTTTAAA | |
| SDM-fw-mut | TAGTATCCCATGAG | |
| SDM-rv-nat | ATGGGATACTATAAATTTCTTGTAGGCA | |
| SDM-rv-mut | ATGGGATACTAT | |
Sequence in bold: artificial ribosome binding site/mutated sequence.
Sequence underlined: linker sequence for hybridization.
Sequence in italic: restriction site.
Sequence motif mutated by site-directed mutagenesis.
Figure 1Co-occurrence of homologs of . The genetic organization of crtR homologs and genes relevant for carotenoid biosynthesis is depicted for representative genomes containing a crtR homologue and at least one gene of carotenogenesis (s. also Figures S1, S3). crtR, regulator of carotenoid biosynthesis and its homologs (in red); crtE/idsA, geranygeranyl diphosphate synthase; crtB, phytoene synthase; crtI, phytoene dehydratase; crtYe/f, C50 epsilon cyclase; crtEb, lycopene elongase, crtX, carotenoid glycosyl transferase, mmpl, putative RND drug exporter; mmpl', pseudogene with homology to mmpl; lpc, putative lipocalin; phr, putative deoxyribopyrimidine photolyase; epi, putative NDP sugar epimerase; idi, isopentenyl diphosphate isomerase; crtEb/ubiA, prenyltransferases; P450, cytochrome P450 monooxygenase; mptA, α(1→6) mannopyranosyltransferase; ubiE, ubiquinone biosynthesis methyltransferase; crtU, β-carotene desaturase/isorenieratene synthase; crtY, lycopene cyclase (no significant homology to CrtYe/f from C. glutamicum); hr, hemerythrin.
Genes differentially expressed in .
| Gene ID | Gene name | Annotation | LB | CgXII |
| cg0717 | Lycopene elongase | 34 | 13 | |
| cg0718 | C50 carotenoid epsilon cyclase | 33 | 35 | |
| cg0719 | C50 carotenoid epsilon cyclase | 69 | 24 | |
| cg0720 | Phytoene dehydrogenase (desaturase) | 36 | 32 | |
| cg0721 | Phytoene synthase | 55 | 45 | |
| cg0722 | − | Putative multidrug efflux protein, resistance-nodulation-cell division (RND) superfamily | 13 | 22 |
| cg0723 | GGPP synthase | 33 | 40 | |
| cg0726 | − | Putative secreted lipoprotein | 8 | 10 |
Average ratio of medians. Only genes regulated more than 2-fold in at least one strain were considered.
Only results with a p-value (adjusted with the False Discovery Rate approach) of ≤ 0.05 were considered to be significant. Three biological replicates were performed.
Effect of .
| MB001 | 0.21 ± 0.01 | 0.47 ± 0.02 | 3.89 ± 0.17 | 0.26 ± 0.01 | 0.79 ± 0.03 |
| MB001Δ | 0.20 ± 0.01 | 2.64 ± 0.09 | 4.12 ± 0.01 | 0.57 ± 0.01 | 0.82 ± 0.02 |
| MB001 | 0.21 ± 0.01 | 0.63 ± 0.01 | 0.48 ± 0.01 | 0.63 ± 0.02 | 0.45 ± 0.01 |
| MB001Δ | 0.20 ± 0.01 | 1.10 ± 0.01 | 0.46 ± 0.03 | 1.43 ± 0.01 | 0.44 ± 0.02 |
GFP.
Figure 2DNA-binding studies of purified CrtR. Promoter region of crtE/crtR and fragments used for electromobility shift assay (EMSA) (a). In green putative binding motifs (M1 and M2) are depicted and in red the respective mutations. The transcriptional start site of the crt-operon is depicted as C in bold (Heider et al., 2012). Fragment A represents the full length intergenic region of crtE and crtR including both translational starts (in bold letters). Fragment B,C,H,I, and K are shortened from the 3′ end, possessing either the original sequence (B, C) or mutations (H, I, K). Fragments D, E, F, and G were ‘successively shortened from the 5′ end and’ constructed with an extra 190 bp downstream of the crtR translational start codon. (b) EMSA with fragment C and different molar rations of purified CrtRHis6 from 0 (no protein added), 15, 20, 25, 30, 40, 50, and 60-fold molar excess. As a control the 5′UTR of cg2228 was used. (c) EMSA with 3′ (B, C) and 5′ (D, E, F, G) truncated fragments of the crtE-crtR intergenic region as depicted in a) and 30-fold molar excess of purified CrtRHis6. (d) EMSA with 3′ truncated fragment C and mutated fragments (H, I, K) and 30-fold molar excess of purified CrtRHis6.
Figure 3Electromobility shift assay of purified CrtR. Analysis of phosphorylated intermediates from the carotenoid biosynthesis pathway as potential effector molecules on the interaction of CrtRHis6 with the full length intergenic region of crtE and crtR. The purified CrtRHis6 was used in 30 molar excess and the effector molecules were used in depicted concentrations.
Decaprenoxanthin accumulation and growth rates in the presence and absence of the .
| WT | 0.24 ± 0.03 |
| WT Δ | 3.57 ± 0.12 |
| WT (pVWEx1) | 0.29 ± 0.01 |
| WT (pVWEx1- | 0.05 ± 0.01 |
| MB001Δ | 4.07 ± 0.69 |
| MB001Δ | 0.04 ± 0.01 |
| MB001(pVWEx1) | 0.12 ± 0.01 |
C50 carotenoid quantities are given as β-carotene equivalents. Cells were grown in glucose CGXII minimal medium for 24 h induced by 1 mM IPTG. Mean values and standard deviations of three replicates are given.
Figure 4Application of regulator engineering on C40 and C50 carotenoid producing . C50 carotenoid quantities are given as β-carotene equivalents. Cells were grown in glucose CGXII minimal medium for 24 h induced by 1 mM IPTG. Mean values and standard deviations of three biological triplicates are given [except LYC5ΔcrtR (pEKEx3-crtE2Y)]. Data from WT and WTΔcrtR are taken from Table 3. p < 0.05 between control and ΔcrtR strains in students t-test (two-sided, unpaired). Gray, decaprenoxanthin; pink; lycopene; light orange, β-carotene; yellow, sarcinaxanthin; red, C.p.450.